|
|
Post by mango on Apr 11, 2017 3:26:38 GMT -5
|
|
|
|
Post by dejude42 on May 28, 2017 8:18:04 GMT -5
The Question of time with safe successful continuous usage is proving a successful drug. This article from April 2014 is long, but word search with "Mannkind". The story of Afrezza and Technosphere with documented testimonies of doctors, management and beginning diabetic users still exist today. I read many times " Afrezza is a Niche Drug". A niche by Webster dictionary is defined as the best person, thing or object for the intended purpose. Imagine preparing for a shot and waiting for results in testing and retesting. Afrezza could not have been placed in a better time period, Affordable electronic monitors providing the proof with real absolute data. Thanks for sharing. May Mannkind sales growth allow the Reverse split Reversal for the needed dilution. I want my shares back! |
|
